Association for Research in Vision and Ophthalmology

Association for Research in Vision and Ophthalmology

June 18, 2019
1 min read

Retinitis pigmentosa stem cell study tops ARVO news

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

The annual Association for Research in Vision and Ophthalmology meeting was held in Vancouver, British Columbia, from April 28 to May 2.

Here are the top five stories and videos from’s coverage of the meeting:


Phase 2a study shows improved vision with stem cell therapy for retinitis pigmentosa

Human retinal progenitor cell therapy from ReNeuron Group is showing positive preliminary results in the company’s ongoing phase 1/2a clinical trial involving patients with retinitis pigmentosa. Read more.


Most weight loss strategies associated with increased risk of glaucoma

Eating less was the only weight loss strategy found to decrease the odds of developing glaucoma, according to a poster. Read more.


Roche-Genentech sees future for AI in retinal disease prevention

Executives and researchers shared their vision at a company-sponsored event for the potential of using technology for not only personalized treatment but disease prevention. Read more.


VIDEO: Wet AMD gene therapy trial shows optimistic results

Allen C. Ho, MD, of Wills Eye Hospital discusses phase 1/2 data from a clinical trial of a gene therapy treatment candidate for wet age-related macular degeneration. Watch here.


Retinal changes may reflect dementia progression

Results of a cross-sectional prospective study showed that several retinal changes were associated with both posterior cortical atrophy and typical Alzheimer’s disease. Read more.